[{"drug1": "magnesium", "drug2": "magnesium salt", "polarity": ["false"], "orig_sen": "Physiological oral magnesium supplementation (5 mg/kg/day) is easy and can be carried out in the diet or with magnesium salts, with practically only one contra-indication: overt renal failure. "}, {"drug1": "25-Dihydroxycholecalciferol D3", "drug2": "vitamin D", "polarity": ["false"], "orig_sen": "1,25-Dihydroxycholecalciferol D3 (1,25(OH)2D3), the active metabolite of vitamin D, is a potent inhibitor of breast cancer cell growth both in vivo and in vitro. "}, {"drug1": "25-Dihydroxycholecalciferol D3", "drug2": "1,25(OH)2D3", "polarity": ["false"], "orig_sen": "1,25-Dihydroxycholecalciferol D3 (1,25(OH)2D3), the active metabolite of vitamin D, is a potent inhibitor of breast cancer cell growth both in vivo and in vitro. "}, {"drug1": "synthetic steroidal estrogen", "drug2": "synthetic steroidal progestogen", "polarity": ["false"], "orig_sen": "Changes in urinary homocysteine following synthetic steroidal estrogen and progestogen administration to rats."}, {"drug1": "(-)-NANM", "drug2": "(+)-NANM", "polarity": ["false"], "orig_sen": "In pigeons, naloxone did not systematically alter the effects of (-)-NANM, (+)-NANM or PCP. "}, {"drug1": "(-)-NANM", "drug2": "(+)-NANM", "polarity": ["false"], "orig_sen": "In monkeys, the effects of (-)-NANM, but not (+)-NANM or PCP, were antagonized by naloxone; "}, {"drug1": "(-)-NANM", "drug2": "(+)-NANM", "polarity": ["false"], "orig_sen": "In both species, (-)-NANM, but not (+)-NANM, antagonized the rate-decreasing effects of morphine on FI and FR responding. "}, {"drug1": "(+)-NANM", "drug2": "(-)-NANM", "polarity": ["false"], "orig_sen": "In monkeys, (-)-NANM was about 10 times more potent than (+)-NANM in decreasing responding, whereas in pigeons (-)-NANM was about equipotent with (+)-NANM. "}, {"drug1": "(-)-NANM", "drug2": "(+)-NANM", "polarity": ["false", "false", "false"], "orig_sen": "In monkeys, (-)-NANM was about 10 times more potent than (+)-NANM in decreasing responding, whereas in pigeons (-)-NANM was about equipotent with (+)-NANM. "}, {"drug1": "arsenate", "drug2": "As(V)", "polarity": ["false"], "orig_sen": "The intestinal absorption of arsenate(As(V)) has been investigated in the chick by means of the in situ ligated duodenal loop technique. "}, {"drug1": "thiazide diuretics", "drug2": "ACE inhibitors", "polarity": ["false"], "orig_sen": "No interactions have been observed with beta-receptor blockers, calcium antagonists, thiazide and loop diuretics and ACE inhibitors. "}, {"drug1": "thiazide diuretics", "drug2": "loop diuretics", "polarity": ["false"], "orig_sen": "No interactions have been observed with beta-receptor blockers, calcium antagonists, thiazide and loop diuretics and ACE inhibitors. "}, {"drug1": "calcium antagonists", "drug2": "thiazide diuretics", "polarity": ["false"], "orig_sen": "No interactions have been observed with beta-receptor blockers, calcium antagonists, thiazide and loop diuretics and ACE inhibitors. "}, {"drug1": "beta-receptor blockers", "drug2": "thiazide diuretics", "polarity": ["false"], "orig_sen": "No interactions have been observed with beta-receptor blockers, calcium antagonists, thiazide and loop diuretics and ACE inhibitors. "}, {"drug1": "CYP2C9", "drug2": "CYP2C9", "polarity": ["false"], "orig_sen": "The genotypes of CYP2C9 and 2C19, the enzymes responsible for phenytoin metabolism, were homozygous for the wild-type alleles (CYP2C9*1/*1 and 2C19*1/ *1). "}, {"drug1": "NaCMC", "drug2": "CMC-Cys", "polarity": ["false"], "orig_sen": "Formulation of fluorescence labelled bacitracin and insulin in unconjugated NaCMC (1% m/v) did not significantly improve the permeation, however in the presence of 1% (m/v) CMC-Cys7.3 a significantly improved permeation was observed (R= 1.3). "}, {"drug1": "insulin", "drug2": "CMC-Cys", "polarity": ["false"], "orig_sen": "Formulation of fluorescence labelled bacitracin and insulin in unconjugated NaCMC (1% m/v) did not significantly improve the permeation, however in the presence of 1% (m/v) CMC-Cys7.3 a significantly improved permeation was observed (R= 1.3). "}, {"drug1": "bacitracin", "drug2": "CMC-Cys", "polarity": ["false"], "orig_sen": "Formulation of fluorescence labelled bacitracin and insulin in unconjugated NaCMC (1% m/v) did not significantly improve the permeation, however in the presence of 1% (m/v) CMC-Cys7.3 a significantly improved permeation was observed (R= 1.3). "}, {"drug1": "antiretroviral drugs", "drug2": "antineoplastic drugs", "polarity": ["true"], "orig_sen": "However, careful attention must be directed to cross toxicity and possible pharmacokinetic interactions between antiretroviral and antineoplastic drugs. "}, {"drug1": "delta(1)-selective opioids", "drug2": "kappa-selective opioids", "polarity": ["false"], "orig_sen": "The percentage of neurons hyperpolarized by mu-, delta(1)-, and kappa-selective opioids was significantly reduced when 1% but not < "}, {"drug1": "mu-selective opioids", "drug2": "kappa-selective opioids", "polarity": ["false"], "orig_sen": "The percentage of neurons hyperpolarized by mu-, delta(1)-, and kappa-selective opioids was significantly reduced when 1% but not < "}, {"drug1": "mu-selective opioids", "drug2": "delta(1)-selective opioids", "polarity": ["false"], "orig_sen": "The percentage of neurons hyperpolarized by mu-, delta(1)-, and kappa-selective opioids was significantly reduced when 1% but not < "}]